Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,779
datasets available to search
ShareScore release 0.9.0
Dataset results
1,779 results for “Hodgkin lymphoma”
Safety Study of CAT-8015 to Treat Advanced B-cell Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia (NHL or CLL)
ClinicalTrials.gov study NCT01030536. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Safety and Efficacy Study of I-131 Tositumomab in Patients With Relapsed/Refractory Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00484874. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of MabThera/Rituxan (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT01998893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study Comparing Inotuzumab Ozogamicin In Combination With Rituximab Versus Defined Investigator's Choice In Follicular Non-Hodgkin's Lymphoma (NHL)
ClinicalTrials.gov study NCT00562965. IPD Sharing: Not stated. Countries: 14. Publications: 0.
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas
ClinicalTrials.gov study NCT01732913. IPD Sharing: YES. Countries: 19. Publications: 0.
LSA4 Protocol for the Treatment of Advanced Pediatric and Adolescent Non-Hodgkins Lymphoma
ClinicalTrials.gov study NCT00610883. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors
ClinicalTrials.gov study NCT00746603. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Panobinostat Plus Ifosfamide, Carboplatin, and Etoposide (ICE) Compared With ICE For Relapsed Hodgkin Lymphoma
ClinicalTrials.gov study NCT01169636. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00863369. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pembrolizumab (MK-3475) in Relapsed or Refractory Classical Hodgkin's Lymphoma (rrcHL) or Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma (rrPMBCL) (MK-3475-B68)
ClinicalTrials.gov study NCT04875195. IPD Sharing: YES. Countries: 11. Publications: 0.
Phase 2 Study of Atorvastatin Safety and Antitumor Effects in Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00185731. IPD Sharing: NO. Countries: 1. Publications: 0.
Larotrectinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With NTRK Fusions (A Pediatric MATCH Treatment Trial)
ClinicalTrials.gov study NCT03213704. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Umbilical Cord Blood NK Cells, Rituximab, High-Dose Chemotherapy, and Stem Cell Transplant in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT03019640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov study NCT00383565. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rituximab and Dexamethasone in Treating Patients With Low-Grade Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00244855. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Oblimersen Sodium and Rituximab in Treating Patients With Recurrent B-cell Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00054639. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical and Immunological Evolution of Covid-19 Occurring in a Context of Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT04641806. IPD Sharing: UNDECIDED. Countries: 0. Publications: 1.
Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT00784927. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluate the Efficacy and Safety of Rasburicase (Fasturtec®) in the Prevention and Treatment of Hyperuricemia in Pediatric Patients With Non-Hodgkin's Lymphoma and Acute Leukemia
ClinicalTrials.gov study NCT04349306. IPD Sharing: YES. Countries: 1. Publications: 0.
VELCADE®-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Non-Hodgkin's Lymphoma, or Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00571493. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.